Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep 14;26(3):128-134.
doi: 10.7812/TPP/21.237. Epub 2022 Jul 20.

Cerebral Venous Sinus Thrombosis Following COVID-19 and Otogenic Infection: A Diagnostic and Therapeutic Dilemma Followed by mRNA COVID-19 Vaccination

Affiliations
Case Reports

Cerebral Venous Sinus Thrombosis Following COVID-19 and Otogenic Infection: A Diagnostic and Therapeutic Dilemma Followed by mRNA COVID-19 Vaccination

Lauren Cline et al. Perm J. .

Abstract

IntroductionCerebral venous sinus thrombosis (CVST) is a rare neurovascular emergency that has been observed following COVID-19 infection, as well as following the use of non-mRNA COVID-19 vaccines. Case PresentationThe authors report a case of CVST in a 67-year-old woman, unvaccinated for COVID-19, who presented with acute otitis externa. It remains unclear whether the CVST was a following COVID-19 infection complication, otogenic CVST, or a combination of both. ConclusionThis case demonstrates the diagnostic and therapeutic dilemmas in managing this patient's challenging anticoagulation and antibiotic duration, as well as subsequent COVID-19 vaccination recommendations.

Keywords: COVID-19; acute otitis externa; case report; cerebral venous sinus thrombosis; vaccine-induced thrombotic thrombocytopenia.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared

Figures

Figure 1:
Figure 1:
Magnetic resonance imaging of brain.

Similar articles

Cited by

  • Intracranial complications of sinogenic and otogenic infections in children: an ESPN survey on their occurrence in the pre-COVID and post-COVID era.
    Massimi L, Cinalli G, Frassanito P, Arcangeli V, Auer C, Baro V, Bartoli A, Bianchi F, Dietvorst S, Di Rocco F, Gallo P, Giordano F, Hinojosa J, Iglesias S, Jecko V, Kahilogullari G, Knerlich-Lukoschus F, Laera R, Locatelli D, Luglietto D, Luzi M, Messing-Jünger M, Mura R, Ragazzi P, Riffaud L, Roth J, Sagarribay A, Pinheiro MS, Spazzapan P, Spennato P, Syrmos N, Talamonti G, Valentini L, Van Veelen ML, Zucchelli M, Tamburrini G. Massimi L, et al. Childs Nerv Syst. 2024 Apr;40(4):1221-1237. doi: 10.1007/s00381-024-06332-9. Epub 2024 Mar 8. Childs Nerv Syst. 2024. PMID: 38456922 Free PMC article.

References

    1. Ferro JM, Correia M, Pontes C, Baptista MV, Pita F. Cerebral vein and dural sinus thrombosis in Portugal: 1980-1998. Cerebrovasc Dis. 2001;11(3):177–182. 10.1159/000047635 - DOI - PubMed
    1. Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: A cross-sectional study. Stroke. 2012;43(12):3375–3377. 10.1161/STROKEAHA.112.671453 - DOI - PubMed
    1. Devasagayam S, Wyatt B, Leyden J, Kleinig T. Cerebral venous sinus thrombosis incidence is higher than previously thought: A retrospective population-based study. Stroke. 2016;47(9):2180–2182. 10.1161/STROKEAHA.116.013617 - DOI - PubMed
    1. Riley DS, Barber MS, Kienle GS, Aronson JK, von SchoenAngerer T, et al. . CARE 2013 explanation and elaborations: Reporting guidelines for case reports. JClinEpi. 2017;89:218–235. 10.1016/j.jclinepi.2017.04.026 - DOI - PubMed
    1. Almarcha-Menargues ML, Martínez-Martínez MM, Fernández-Travieso J. SARS-CoV-2 infection: Possible underdiagnosis of cerebral venous sinus thrombosis. Neurologia (Engl Ed). 2021;36(7):575–576. 10.1016/j.nrleng.2021.06.003 - DOI - PMC - PubMed

Publication types